U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07906314) titled 'Post-Market Registry Study for Vibrant Hearing Solutions' on Oct. 23.
Brief Summary: This observational registry collects retrospective and prospective, data from children and adults who use CE-marked MED-EL implantable (PMEI, BCI, or AMEI) or non-implantable (BCD) hearing solutions as part of routine care. Participants will be followed long term, potentially up to the lifetime of their hearing solution, to assess quality of life, hearing and speech performance, and device use. Data will be collected using routinely administered clinical tests and questionnaires to evaluate real-world outcomes across diverse populations and MED-EL h...